Core Vct I Share Discussion Threads

[cpap man] 17/4/2018 17:27

AST



xow9817 Apr '18 - 17:18 - 3129 of 3130

[...]

Ascent Resources (AST LN – 0.75p) – Next Step: Today’s announcement that all strategic options for the valorisation of the Petišovci asset will be undertaken is a surprise, not least as the management team have seen the Company through the most testing of times and appeared to be in a position where life was about to get easier. Saying that, you can’t fault the team for studying all opportunities and strategies available to enable value creation for shareholders. In doing this, the team have taken the step of reducing the uncertainty that can surround potential routes to valorisation, which to our mind confirms their leadership position. On the back of this news shareholders should be pleased with their management team and that the outcome, whichever is chosen, will be the most optimal to achive that value creation.

[cpap man] 17/4/2018 16:17

VLS



kirk 617 Apr '18 - 15:16 - 1439 of 1442

Always said fair value here above 40p after the fundraise! Should not be trading here

And that would close the GAP on the VLS chart of course!

[sweepie2] 17/4/2018 16:08

Tern's 56% investment in DA looks better and better with every release, DA firing on all cylinders with 6 news releases this month alone, todays looks a cracking one, read and enjoy this story as it unfolds

London, UK – 17th April 2018 – The MULTOS Consortium, a group of international blue chip organisations responsible for the promotion and development of the MULTOS specifications, announced today that Device Authority, a global leader in Identity and Access Management (IAM) for the Internet of Things (IoT), has joined as a Partner Member.

As a member, Device Authority will participate in the MULTOS Business and Technical Advisory Groups which will allow them to contribute towards the development and growth of MULTOS whilst benefiting from the Consortium’s marketing, technical, and networking resources with members that span the digital security and smart device industries.

With increasing connectivity established for consumer and business IoT devices, the cyber security risk also continues to increase. The need for robust digital security to help businesses ensure they protect their data, their assets, and their reputations is growing. Root of trust solutions such as MULTOS are critical to deliver the protection many IoT businesses require.

Device Authority’s KeyScaler platform extends the options available for organisations wishing to benefit from a trusted hardware secured IoT device. Solution providers and OEMs can reduce their time to market by leveraging these established, reliable security components which fully integrate with several IoT platforms. Flexibility and security are core benefits which can be leveraged by implementing this combined solution.

“Working with the MULTOS Consortium and technology, Device Authority’s KeyScaler platform with PKI Signature+ authentication can provide a powerful IoT endpoint and device management solution using a hardware root of trust, addressing a wide market of IoT opportunities”, said Darron Antill, CEO of Device Authority. “We are excited to develop our new partnership with the MULTOS Consortium and provide valuable security for customers deploying IoT solutions.”

Paul Wilson, Commercial Manager of the MULTOS Consortium said “It is a real pleasure to welcome Device Authority to the growing MULTOS Consortium and eco-system. Since we first announced a collaborative venture with Device Authority back in 2017, it has been clear to see the potential mutual value they can offer. A MULTOS secured endpoint in conjunction with Device Authority’s KeyScaler platform, can allow businesses to protect their assets, their services, and their reputations. As security becomes an increasing concern for connected IoT systems a stronger partnership between Device Authority and the MULTOS technology and community is a positive step forward to helping protect client’s devices and solutions”.

[cpap man] 17/4/2018 15:02

VLS



Just for those who want to follow Velocys [VLS]

The management are doing a much better job of PR on the Twitter page. It is very informative!

[argy4] 17/4/2018 13:56

CLP

Ticking up again.

Looking to push through 1p very soon.

[cpap man] 17/4/2018 10:42

WRES



W Resources Plc

("W" or the "Company")



Tungsten, Copper and Gold Update



W Resources Plc (AIM:WRES), the tungsten, copper and gold, exploration and development company with assets in Spain and Portugal, has achieved critical financing milestones over the last three months with the US$35m BlackRock Financial Management Inc. ("BlackRock") financing and US$7m (€5.3m) in government grants awarded for the La Parrilla mine in Spain, and the completion of a £1.5m financing for its Portuguese growth projects. With this strong sustaining base in place, the absolute priority for the Company is to deliver the fully financed La Parrilla T2 development on budget and on schedule.

In parallel, the Company is pleased to provide an update on its Portuguese tungsten projects Régua and Tarouca in addition to the Copper Gold projects São Martinho, Monforte-Tinoca and Portalegre.

The recently completed Placing, together with internal cash resources provides the base for W to add significant value to its Tungsten, Copper and Gold assets in Portugal for a relatively low investment.

Régua is fully approved for trial mine development. Infill drilling will be completed on the entrance to the two high-grade mine adits in the mine in Q2 and initial road construction will commence. The FID plan will then be finalised in Q3, and subject to a satisfactory FID mining will then commence in Q4.

In parallel, a 1,500m RC drilling programme will be completed in the high grade Tarouca deposit, located just 20km south of Régua, with the target of working up a mineral resource to then feed additional high-grade tonnes into Régua. This work will be completed in Q2 with resource estimation planned in H2 2018.

At the São Martinho gold deposit the team will carry out a 2,000m RC drilling programme in Q2, with a view to materially increase the resource, following which the resource estimation update will be completed in H2 2018.

The Monforte-Tinoca Copper projects will also be advanced over the next six months. Geophysics surveys are currently underway using both Induced Polarisation / Electric Resistivity and Transient Electromagnetics methods across the target Copper zones. The geophysics surveys are expected to pin point the copper anomaly and extensions of the former high-grade copper mines. RC drilling (1,500m in total) is expected to commence in H2 2018.

Following the successful BlackRock financing, which takes a senior secured position over both the Spanish and Portuguese assets, the Company's plan is to add very significant value to the copper gold assets during 2018 and add additional licenses and projects to the current portfolio prior to a potential spin-off or sale of Copper Gold Resources Plc. With management's priority and focus on the successful execution of La Parrilla, it is most efficient for the dedicated Portuguese technical team to advance the assets prior to spin-off or sale.

Commenting, Michael Masterman, Chairman of W Resources said: "2018 is set to be a very exciting year for W with significant development work across our portfolio of tungsten, gold and copper projects. With great progress being made at La Parrilla we are delighted to also progress our tungsten, copper and gold assets and build further value for shareholders."

[cpap man] 17/4/2018 10:33

KOD



Kodal Minerals* (KOD LN) 0.162p, mkt cap £10.6m – Confirmation of licences over high priority targets at Bougouni

Kodal Minerals that it has received “fully signed “conventions” in respect of applications over two new high priority areas within the Kolassokoro area” at its Bougouni Lithium project in Southern Mali. The areas are each of 100km2

The licences, issued in the name of Kodal Minerals’ Malian subsidiary, Future Minerals, ensure exploration rights for an initial three year period and contain the rights to two further renewals each of two years.

*SP Angel act as Financial Advisor and broker to Kodal Minerals. A partner at share price Angel acts as Chairman to the company.

[cpap man] 17/4/2018 07:52

KOD



Edgein17 Apr '18 - 07:50 - 415 of 415

DJJ,

Not exactly, now they have a 3 year term so they've longer on the licences and moreover the amount of lith is significantly more in terms of strike length (850m+) and grade (up to 7.15%). And about to start bulk sample. They're significantly further on than when the licence issue arose and when SC bought in at 0.38p. But this confirms that the licences and assets belong to KOD for the foreseeable future. They should really be trading higher than the SC buy in price given operational progress and the Chinese support here.

Regards,
Ed.

[cpap man] 17/4/2018 07:48

AST



Ascent Resources plc

("Ascent" or the "Company")

Strategic review including formal sale process under the Takeover Code

Ascent Resources plc (AIM: AST), the AIM quoted European oil and gas exploration and production company, today announces that it has decided to conduct a review of the various strategic options available to the Company to maximise value for its shareholders. This will include seeking both to identify a partner to work with the Company to maximise the opportunities to develop its existing assets, and offers for the Company.

Since the current board came together in 2012/13, the primary focus has been on moving the Company from its then parlous financial state to becoming operationally cashflow positive. This was achieved, as announced on 3 November 2017, with the delivery of first export gas production from its primary asset in the Petišovci field in Slovenia.

However, the Board has concluded that the planned further development of the Petišovci project, and the potential diversification into other regional projects, is currently not an option available to the Company without the potential of significant dilution for shareholders.

The Company has received several expressions of interest from industry players interested in working with the Company to expedite the development of Petišovci, including through farm-outs and general strategic partnerships. These discussions are all at an early stage and there can be no assurance that any of them will result in a transaction acceptable to the Company. The Company is not currently in receipt of any approach with regard to a possible offer and is not in talks with any potential offeror.

Following receipt of the expressions of interest, the Board has decided to take a proactive approach and initiate a strategic review, including a formal sale process under the City Code on Takeovers and Mergers (the "Takeover Code").

In this regard, the Company has engaged GMP FirstEnergy, an independent oil and gas advisory firm. Parties with a potential interest in making a proposal should contact David van Erp or Jonathan Wright at GMP FirstEnergy LLP ([phone]).

Colin Hutchinson, Chief Executive Officer, today commented: "Since successfully becoming cashflow positive, the Board has now decided to undertake a corporate review of the Company, focussed on assessing how value can most effectively be generated for Ascent's shareholders. It is naturally appropriate for a company such as ourselves, with a highly valuable gas asset, to be in non-exclusive discussion with third parties. We are confident that the review will allow us to face the future with optimism, and we look forward to providing a further update on our intended focus in due course".

[cpap man] 17/4/2018 07:47

AST



Ascent Resources plc / Epic: AST / Index: AIM / Sector: Oil and Gas

17 April 2018

Ascent Resources plc

("Ascent" or the "Company")

Audited Final Results for the year ended 31 December 2017

Transformational Year

Ascent Resources plc (AIM: AST), the AIM quoted European oil and gas exploration and production company, is pleased to announce its audited full year results for the year ended 31 December 2017.

2017 Highlights

· Profitable, cash generative and debt free

· Producing from a high value gas asset

· Potential to increase production through well recompletions using existing infrastructure

· Cash reserves of over £1 million

The Company has today announced it will conduct a review of the various strategic options available to the Company to maximise value for shareholders.

This will include both, seeking to identify a partner to work with the Company to maximise the opportunities to develop existing assets and offers for the Company.



Colin Hutchinson, CEO of Ascent Resources plc, commented:

"This has been a transformational year for Ascent, as we have moved from an exploration company to a production company. We look forward to our continued success in the future."

[cpap man] 17/4/2018 07:38

AST



MEGA RNS out from AST this morning....



theunluckyone17 Apr '18 - 07:11 - 3055 of 3056



Note :-

"This will include both, seeking to identify a partner to work with the Company to maximise the opportunities to develop existing assets and offers for the Company."

theunluckyone17 Apr '18 - 07:12 - 3056 of 3056

[argy4] 17/4/2018 07:23

RRR



Jupiter Mines - ASX Listing Oversubscribed

17 April 18

Red Rock Resources Plc, the natural resource development company with interests in gold and steel feed materials, announces further to the release of 19 March 18 that Jupiter Mines Limited ("Jupiter"), an Australian public company, has announced the full allocation of its A$240m Initial Public Offering ("IPO"), comprising a A$225m institutional allocation and an A$15m allocation in the general public offer. The IPO was significantly oversubscribed.


At A$240m, the Jupiter IPO, will be one of the largest Initial Public Offerings in the Metals and Mining industry over the last decade. Jupiter is currently expected to begin trading on the ASX at 1100 hrs AEST on 18 April 2018.

As part of the listing process, the Company, along with several other large institutional shareholders in Jupiter agreed to sell part of their holdings to ensure an adequate free float post-listing. Red Rock has now sold 4,700,000 shares, constituting 20.2% of its holding in Jupiter, and has agreed to retain the balance of its 18,524,914 shares in escrow for a period after listing. In consideration for this sale the Company has received AUD1,842,400 after expenses.



Red Rock retains a 0.95% stake in the post IPO share capital of Jupiter, which at the IPO price will be worth AUD 7,409,966.


Andrew Bell, Chairman of Red Rock comments: "The oversubscription of the Jupiter IPO this week completes the multi-year journey undertaken by Jupiter when it originally delisted in 2014 following concerns that its transition from exploration to production had not been adequately reflected in its share price.

Now with several years of increasing manganese production behind it at Tshipi in South Africa, and buoyed by strong manganese prices and an extended track record of dividend payments, we perceive our residual stake in Jupiter to be a key component of our cash generative growth strategy in 2018 and beyond.

[billiondollarbrain] 16/4/2018 15:59

Immupharma (IMM) Phase III Lupuzor results expected this week.

Possible $ multi-billion blockbuster could lead to a massive re-rating of the share price.



This promising small-cap stock could be a millionaire maker in 2018
Paul Summers
26/12/2017



The suggestion that a single stock could lead some investors to become millionaires next year may sound fanciful but I think this is quite possible if events work out for small-cap drug discovery and development firm ImmuPharma (LSE: IMM). Let me explain.

Blockbuster potential

Over the last three months, shares in the AIM-listed company have climbed more than 200% in value as anticipation grows over the outcome of a Phase III clinical trial for Lupuzor — its 100%-owned potential treatment for Lupus.

Approximately five million people are believed to suffer from the chronic and potentially life-threatening autoimmune disease that can be a notoriously difficult to treat. In the last 50 years, only one therapy — GlaxoSmithKline‘s Benlysta — has been approved for use, despite its questionable efficacy and serious side-effects. In 2015, the drug achieved sales of over $400m. By 2020, this figure is expected to rise to $1bn.

Positively, data from Lupozor’s Phase IIb trial indicated that ImmuPharma’s treatment — which modulates rather than blocks the immune system — was both effective and safe. Moreover, the effectiveness of Lupuzor increased even after the three-month trial’s conclusion. Investors will be hoping that the 52-week, randomised and double-blinded study currently in progress (involving patients in the US, Europe and Mauritius) yields similar results.

In its most recent update on 21 December, the company revealed that all 200 participants had now received the full 12-month dosage and that the “robust safety record” shown in earlier trials continues to be seen. According to Chairman Tim McCarthy, the company looks forward “with continued confidence” to reporting on top-line results in Q1 of next year.

In the event of a positive outcome, ImmuPharma will then seek to exploit its Fast Track designation and push for approval from the Food and Drug Administration (FDA). Once received, the company would then be free to seek out a global licensing deal for taking Lupuzor to market or — perhaps more likely — consider takeover bids by deep-pocketed pharmaceutical giants at a price befitting its blockbuster potential. Given the suggestion that it could be used in the treatment of other diseases, the price could easily be in the billions of pounds. Right now, ImmuPharma’s market cap is a little over £200m.

Tempted? If so, it’s vital to consider the flip side of this investment.

Despite the encouraging outcomes of previous trials, the possibility of the drug failing to impress still remains. Plenty of highly promising treatments have disappointed at the last hurdle, resulting in significant capital losses for investors. Unless you’re willing to embrace this level of risk, Immupharma shouldn’t even make it on to your watchlist, let alone into your portfolio.

That’s why — as a holder of its stock — only a small proportion of my capital is invested in the company. This money can be lost. I might grumble and curse but — thanks to a degree of diversification — I won’t lose my shirt.

That said, if — and it remains a sizeable ‘if‘ — Lupuzor proves effective (or at least more efficacious than Benlysta), I’m confident that ImmuPharma could generate huge wealth for investors in a very short time period.

No investment is devoid of risk but only you can decide whether this is one worth taking.

[hope67] 16/4/2018 13:30

C4xd well worth researching

[yawn3] 16/4/2018 08:47

CLP (.85)

Looking to test 1p again soon?

Steady stream of buyers this morning. Any sellers from last placing seem to have dried up now which bodes well if good news hits the market. 1p then 1.2 should go quickly.

[cudmore] 13/4/2018 10:07

UPL and LION......both cracking RNS’s this morning. CLP court case ruling expected this morning with a positive outcome. Will see the shares soar. Get in now!!

[cpap man] 13/4/2018 07:55

KRS



Take a look at recent posts of the main KRS thread

[cpap man] 12/4/2018 14:51

TOM



Have to say that when the dust settles TOM could be worth 100p+

[yawn3] 12/4/2018 14:39

TOM

Don't buy into the TOM spike - its shares are truly worthless

According to The City's No 1 Oil Analyst Zac Phillips at share price Angel.

[tidy 2] 12/4/2018 13:36

Top news. The export route for ZIOC and Glencores worlds 5th largest high grade ore deposit is now under construction 50/50 JV partners 6.9bn tonnes 66-69% premium ore.https://twitter.com/Matthew_hopton/status/984403034301231109

[yawn3] 12/4/2018 12:21

MOS

Be very careful.

[cpap man] 12/4/2018 10:57

ABM



African Battery Metals* (ABM LN) 0.05p, Mkt Cap £2.9m – Cobalt drilling program extended

African Battery Metals report that the company has extended its auger drilling program at its Kisinka copper-cobalt property in the DRC.

Results show elevated levels of cobalt as we would expect in an area where artisanal miners have been seen extracting copper-cobalt ores from surface pits
This is a first pass drilling program to quickly and cheaply extract soil samples above the mineralised bedrock.

The team are using a XRF Niton gun to test results from the auger drilling and will send the more interesting results for laboratory testing in Johannesburg.
This technique is being successfully used by others on adjacent licenses to identify copper-cobalt anomalies.

ABM are also evaluating other copper-cobalt opportunities in the DRC and have an option over a second, Sakania, license which it will investigate.
For further information see: www.abmplc.com

Conclusion: It is good to see the results of field work starting to come through. We expect to see indications of copper-cobalt mineralisation from these results and for this to then direct a more meaningful diamond drill program. We would then hope to see grades and intersections which could drive a conceptual pit study and early stage economic evaluation.

*SP Angel act as broker to African Battery Metals

[yawn3] 12/4/2018 09:21

CLP

Tick Tick. News soon?